======= MEMO1 ======= == Gene Information == * **Official Symbol**: MEMO1 * **Official Name**: mediator of cell motility 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51072|51072]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y316|Q9Y316]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MEMO1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MEMO1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611786|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May control cell migration by relaying extracellular chemotactic signals to the microtubule cytoskeleton. Mediator of ERBB2 signaling. The MEMO1-RHOA-DIAPH1 signaling pathway plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. It controls the localization of APC and CLASP2 to the cell membrane, via the regulation of GSK3B activity. In turn, membrane-bound APC allows the localization of the MACF1 to the cell membrane, which is required for microtubule capture and stabilization. Is required for breast carcinoma cell migration. {ECO:0000269|PubMed:15156151, ECO:0000269|PubMed:20937854}. |Memo| |regulation of microtubule-based process| |regulation of cell motility| |regulation of locomotion| |regulation of cellular component movement| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp435|JQ1 0.8μM R08 exp435]]|-2.46| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|-2.19| |[[:results:exp487|Hinokiflavone 12μM R08 exp487]]|-1.94| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.87| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|-1.7| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|1.76| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|1.78| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|1.81| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|1.82| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|1.84| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|1.85| |[[:results:exp115|A-366 10μM R03 exp115]]|1.86| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|1.86| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|1.91| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|1.93| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|1.94| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|2.05| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|2.14| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|2.19| |[[:results:exp82|Torin1 0.08μM R02 exp82]]|2.22| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|2.26| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|2.31| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|2.32| |[[:results:exp116|AICAR 240μM R03 exp116]]|2.33| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|2.53| |[[:results:exp264|Arsenate 40μM R06 exp264]]|2.59| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|2.84| |[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|2.84| |[[:results:exp504|MK2206 4μM R08 exp504]]|2.86| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|2.88| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|2.9| |[[:results:exp134|MS023 2μM R03 exp134]]|3.14| |[[:results:exp198|Etoposide 0.1μM R05 exp198]]|3.16| |[[:results:exp485|GSK626616 14μM R08 exp485]]|3.21| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|3.25| |[[:results:exp120|Dimethyl-Sulfoxide 1pc R03 exp120]]|3.34| |[[:results:exp429|Rapamycin 0.001μM R08 exp429]]|3.43| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|3.45| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|3.54| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|3.88| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|4.68| ^Gene^Correlation^ |[[:human genes:y:ypel5|YPEL5]]|0.587| |[[:human genes:u:ube2h|UBE2H]]|0.58| |[[:human genes:w:wdr26|WDR26]]|0.526| |[[:human genes:a:anp32a|ANP32A]]|0.513| |[[:human genes:k:kdm6a|KDM6A]]|0.494| |[[:human genes:c:cdk8|CDK8]]|0.491| |[[:human genes:f:fam122a|FAM122A]]|0.463| |[[:human genes:z:znf148|ZNF148]]|0.459| |[[:human genes:g:gid8|GID8]]|0.435| |[[:human genes:m:mettl23|METTL23]]|0.426| |[[:human genes:m:maea|MAEA]]|0.426| |[[:human genes:s:son|SON]]|0.424| |[[:human genes:g:gskip|GSKIP]]|0.415| |[[:human genes:f:fkbp1a|FKBP1A]]|0.414| |[[:human genes:c:cnot2|CNOT2]]|0.409| |[[:human genes:a:arid4b|ARID4B]]|0.406| |[[:human genes:a:ammecr1|AMMECR1]]|0.405| |[[:human genes:z:zbtb18|ZBTB18]]|0.401| Global Fraction of Cell Lines Where Essential: 4/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12735 * **Expression level (log2 read counts)**: 5.31 {{:chemogenomics:nalm6 dist.png?nolink |}}